Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis

Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice

(2016) Camella G. Wilson et al.   ENDOCRINOLOGY

Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease

(2016) Fareeba Sheedfar et al.   Aging-US

Inhibition of CYP4A Reduces Hepatic Endoplasmic Reticulum Stress and Features of Diabetes in Mice

(2014) Edmond Changkyun Park et al.   GASTROENTEROLOGY

Comparative proteomic study reveals 17 -HSD13 as a pathogenic protein in nonalcoholic fatty liver disease

(2014) W. Su et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hepatic Overexpression of ATP Synthase   Subunit Activates PI3K/Akt Pathway to Ameliorate Hyperglycemia of Diabetic Mice

(2013) C. Wang et al.   DIABETES

FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis

(2013) Chunjiong Wang et al.   HEPATOLOGY

Hormonal regulation of Cyp4a isoforms in mouse liver and kidney

(2013) Youcai Zhang et al.   XENOBIOTICA

Modulations of cytochrome P450 expression in diabetic mice by berberine

(2012) Waranya Chatuphonprasert et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C

(2011) M. E. Miquilena-Colina et al.   GUT

CD36 as a lipid sensor

(2011) Céline Martin et al.   PHYSIOLOGY & BEHAVIOR

Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis

(2010) Lars P. Bechmann et al.   LIVER INTERNATIONAL

Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet☆

(2010) Yu-Kun Jennifer Zhang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior

(2009) R. L. Silverstein et al.   Science Signaling

Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases

(2008) James P. Hardwick   BIOCHEMICAL PHARMACOLOGY

Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)

(2008) G MUSSO et al.   PROGRESS IN LIPID RESEARCH

Hepatic effects of a methionine–choline-deficient diet in hepatocyte RXRα-null mice

(2008) Maxwell Afari Gyamfi et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury

(2007) Maxwell Afari Gyamfi et al.   BIOCHEMICAL PHARMACOLOGY